These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22990555)

  • 21. Liver fibrosis is associated with carotid atherosclerosis in patients with liver biopsy-proven nonalcoholic fatty liver disease.
    Arai T; Atsukawa M; Tsubota A; Kato K; Abe H; Ono H; Kawano T; Yoshida Y; Tanabe T; Okubo T; Hayama K; Nakagawa-Iwashita A; Itokawa N; Kondo C; Kaneko K; Emoto N; Nagao M; Inagaki K; Fukuda I; Sugihara H; Iwakiri K
    Sci Rep; 2021 Aug; 11(1):15938. PubMed ID: 34354193
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study.
    Tarnoki AD; Tarnoki DL; Bata P; Littvay L; Osztovits J; Jermendy G; Karlinger K; Lannert A; Preda I; Kiss RG; Molnar AA; Garami Z; Baffy G; Berczi V
    Liver Int; 2012 Sep; 32(8):1287-93. PubMed ID: 22651705
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nonalcoholic fatty liver is not associated with carotid intima-media thickness in type 2 diabetic patients.
    Petit JM; Guiu B; Terriat B; Loffroy R; Robin I; Petit V; Bouillet B; Brindisi MC; Duvillard L; Hillon P; Cercueil JP; Verges B
    J Clin Endocrinol Metab; 2009 Oct; 94(10):4103-6. PubMed ID: 19584186
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis.
    Adinolfi LE; Restivo L; Zampino R; Guerrera B; Lonardo A; Ruggiero L; Riello F; Loria P; Florio A
    Atherosclerosis; 2012 Apr; 221(2):496-502. PubMed ID: 22385985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated asymmetric dimethylarginine in plasma: an early marker for endothelial dysfunction in non-alcoholic fatty liver disease?
    Dogru T; Genc H; Tapan S; Ercin CN; Ors F; Aslan F; Kara M; Sertoglu E; Bagci S; Kurt I; Sonmez A
    Diabetes Res Clin Pract; 2012 Apr; 96(1):47-52. PubMed ID: 22189171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.
    Sato M; Kamada Y; Takeda Y; Kida S; Ohara Y; Fujii H; Akita M; Mizutani K; Yoshida Y; Yamada M; Hougaku H; Takehara T; Miyoshi E
    Liver Int; 2015 Mar; 35(3):925-35. PubMed ID: 25627311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of early atherosclerosis markers in patients with nonalcoholic fatty liver disease.
    Kucukazman M; Ata N; Yavuz B; Dal K; Sen O; Deveci OS; Agladioglu K; Yeniova AO; Nazligul Y; Ertugrul DT
    Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):147-51. PubMed ID: 23085576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as risk factors for atherosclerosis in patients with nonalcoholic fatty liver disease.
    Aygun C; Kocaman O; Sahin T; Uraz S; Eminler AT; Celebi A; Senturk O; Hulagu S
    Dig Dis Sci; 2008 May; 53(5):1352-7. PubMed ID: 17939039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intima-media thickness and liver histology in obese children and adolescents with non-alcoholic fatty liver disease.
    Manco M; Bedogni G; Monti L; Morino G; Natali G; Nobili V
    Atherosclerosis; 2010 Apr; 209(2):463-8. PubMed ID: 19897197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased arterial stiffness in nonalcoholic fatty liver disease: the Cardio-GOOSE study.
    Salvi P; Ruffini R; Agnoletti D; Magnani E; Pagliarani G; Comandini G; Praticò A; Borghi C; Benetos A; Pazzi P
    J Hypertens; 2010 Aug; 28(8):1699-707. PubMed ID: 20467324
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between left ventricular mass and carotid intima media thickness in obese adolescents with non-alcoholic fatty liver disease.
    Sert A; Pirgon O; Aypar E; Yilmaz H; Odabas D
    J Pediatr Endocrinol Metab; 2012; 25(9-10):927-34. PubMed ID: 23426822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nonalcoholic fatty liver disease (NAFLD) and cardiovascular risk in renal transplant recipients.
    Mikolasevic I; Racki S; Zaputovic L; Lukenda V; Sladoje-Martinovic B; Orlic L
    Kidney Blood Press Res; 2014; 39(4):308-14. PubMed ID: 25300437
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association between nonalcoholic fatty liver disease and cardiovascular risk in obese children and adolescents.
    Alp H; Karaarslan S; Selver Eklioğlu B; Atabek ME; Altın H; Baysal T
    Can J Cardiol; 2013 Sep; 29(9):1118-25. PubMed ID: 23040432
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epicardial Adipose Tissue (EAT) Thickness Is Associated with Cardiovascular and Liver Damage in Nonalcoholic Fatty Liver Disease.
    Fracanzani AL; Pisano G; Consonni D; Tiraboschi S; Baragetti A; Bertelli C; Norata GD; Dongiovanni P; Valenti L; Grigore L; Tonella T; Catapano A; Fargion S
    PLoS One; 2016; 11(9):e0162473. PubMed ID: 27627804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic insulin resistance in NAFLD: relationship with markers of atherosclerosis and metabolic syndrome components.
    Privitera G; Spadaro L; Alagona C; Calanna S; Piro S; Rabuazzo AM; Purrello F
    Acta Diabetol; 2016 Jun; 53(3):449-59. PubMed ID: 26496770
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nonalcoholic Fatty Liver Disease (NAFLD)-A New Cardiovascular Risk Factor in Peritoneal Dialysis Patients.
    Mikolasevic I; Milic S; Racki S; Zaputovic L; Stimac D; Radic M; Markic D; Orlic L
    Perit Dial Int; 2016; 36(4):427-32. PubMed ID: 26475841
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum ferritin levels are associated with vascular damage in patients with nonalcoholic fatty liver disease.
    Valenti L; Swinkels DW; Burdick L; Dongiovanni P; Tjalsma H; Motta BM; Bertelli C; Fatta E; Bignamini D; Rametta R; Fargion S; Fracanzani AL
    Nutr Metab Cardiovasc Dis; 2011 Aug; 21(8):568-75. PubMed ID: 20392616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-alcoholic fatty liver disease is strongly associated with carotid atherosclerosis: a systematic review.
    Sookoian S; Pirola CJ
    J Hepatol; 2008 Oct; 49(4):600-7. PubMed ID: 18672311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonalcoholic fatty liver disease is an independent risk factor for atherosclerosis in young adult men.
    Ozturk K; Uygun A; Guler AK; Demirci H; Ozdemir C; Cakir M; Sakin YS; Turker T; Sari S; Demirbas S; Karslıoğlu Y; Saglam M
    Atherosclerosis; 2015 Jun; 240(2):380-6. PubMed ID: 25875390
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carotid lesions in outpatients with nonalcoholic fatty liver disease.
    Ramilli S; Pretolani S; Muscari A; Pacelli B; Arienti V
    World J Gastroenterol; 2009 Oct; 15(38):4770-4. PubMed ID: 19824109
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.